The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Duplisea, Jonathan J.
Schluns, Kimberly S.
McConkey, David J.
Parker, Nigel R.
Dinney, Colin P.
Funding for this research was provided by:
National Cancer Institute (P50CA091846)
National Institutes of Health (P30CA016672)
Text and Data Mining valid from 2018-11-11